Get the Stockscreener App
4.18
0.48%
0.02
Evolent Health Inc stock is traded at $4.18, with a volume of 6.20M.
It is up +0.48% in the last 24 hours and down -45.78% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$4.16
Open:
$4.03
24h Volume:
6.20M
Relative Volume:
1.82
Market Cap:
$491.19M
Revenue:
$2.35B
Net Income/Loss:
$-74.42M
P/E Ratio:
-4.4468
EPS:
-0.94
Net Cash Flow:
$150.93M
1W Performance:
-15.73%
1M Performance:
-45.78%
6M Performance:
-53.24%
1Y Performance:
-67.01%
1-Day Range:
$4.005
$4.305
1-Week Range:
$4.005
$5.2538
52-Week Range:
$4.005
$13.62
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
4.18 | 464.26M | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
293.36 | 47.81B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
68.48 | 12.09B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
101.77 | 8.57B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
49.62 | 9.36B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.32 | 6.84B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-13-25 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Why Evolent Health Inc. stock is popular among millennialsMarket Weekly Review & Low Volatility Stock Suggestions - newser.com
Published on: 2025-11-15 12:37:56 - newser.com
Will Evolent Health Inc. see short term momentumBond Market & Smart Investment Allocation Insights - newser.com
Is Evolent Health Inc. stock ready for a breakoutGap Down & Stepwise Trade Signal Implementation - newser.com
Evolent Health (EVH): Canaccord Genuity Maintains Buy Rating, Lo - GuruFocus
Is Evolent Health Inc. stock positioned well for digital economyRate Hike & Consistent Income Trade Ideas - newser.com
Aug Levels: How Evolent Health Inc Class stock reacts to Fed tighteningJuly 2025 Fed Impact & Verified Chart Pattern Signals - Fundação Cultural do Pará
Can Evolent Health Inc Class stock sustain margin levels2025 Sector Review & Breakout Confirmation Alerts - Fundação Cultural do Pará
Healthcare Technology for Providers Stocks Q3 In Review: Evolent Health (NYSE:EVH) Vs Peers - Finviz
The Top 5 Analyst Questions From Evolent Health's Q3 Earnings Call - Finviz
Stephens Upgrades Evolent Health Inc to Overweight From Equalweight, Price Target is $7 - MarketScreener
Can Evolent Health Inc. rally from current levelsJuly 2025 Breakouts & AI Driven Stock Price Forecasts - newser.com
BMO Capital Initiates Coverage on Evolent Health With Outperform Rating - MarketScreener
BMO Capital Initiates Coverage of Evolent Health (EVH) with Outperform Recommendation - Nasdaq
EVH: BMO Capital Initiates Coverage with 'Outperform' Rating | E - GuruFocus
Evolent Health (NYSE:EVH shareholders incur further losses as stock declines 30% this week, taking three-year losses to 81% - Yahoo Finance
The Top 5 Analyst Questions From Evolent Health’s Q3 Earnings Call - Yahoo Finance
Why Evolent Health (EVH) Shares Are Sliding Today - Finviz
Will Evolent Health Inc. (9EH) stock benefit from Fed rate cutsStop Loss & Daily Stock Trend Reports - newser.com
Evolent Health initiated with an Outperform at BMO Capital - TipRanks
Evolent Health (EVH) Target Price Lowered by Oppenheimer | EVH S - GuruFocus
Evolent Health price target lowered to $12 from $18 at Oppenheimer - TipRanks
Will Evolent Health Inc Class stock top growth indexesEarnings Overview Report & Advanced Swing Trade Entry Plans - newser.com
Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know - The Globe and Mail
Evolent Health Stock Plummets to New 52-Week Low at $4.92 - Markets Mojo
Evolent Health Stock Hits Day Low of $4.92 Amid Price Pressure - Markets Mojo
UBS Adjusts Price Target on Evolent Health to $10 From $15, Maintains Buy Rating - MarketScreener
How Evolent Health Inc. stock reacts to Fed rate cutsJuly 2025 PostEarnings & Real-Time Volume Analysis - newser.com
Published on: 2025-11-11 04:57:50 - newser.com
What indicators show strength in Evolent Health Inc.Dollar Strength & Low Drawdown Momentum Trade Ideas - newser.com
Evolent Health Inc. stock prediction for this week2025 Price Action Summary & Low Drawdown Trading Strategies - newser.com
Evolent Health (EVH) Analyst Rating Update: Target Price Lowered by Truist Securities | EVH Stock News - GuruFocus
EVH: Analyst Constantine Davides Lowers Price Target to $11 | EV - GuruFocus
Truist Cuts Price Target on Evolent Health to $10 From $16, Keeps Buy Rating - MarketScreener
Evolent Health price target lowered to $11 from $13 at Citizens JMP - TipRanks
Citizens lowers Evolent Health stock price target to $11 on revised EBITDA - Investing.com Canada
Truist Securities lowers Evolent Health stock price target to $10 from $16 - Investing.com Canada
Reversal indicators forming on Evolent Health Inc. stockQuarterly Profit Report & Risk Controlled Swing Alerts - newser.com
What MACD signals say about Evolent Health Inc.Oil Prices & Precise Buy Zone Identification - newser.com
Evolent Health projects $2.5B 2026 revenue with $750M in new contracts while expanding oncology partnerships - MSN
EVH (Evolent Health) ROA % : -3.40% (As of Sep. 2025) - GuruFocus
Evolent Health Inc. Reports Strong Q3 Earnings and Strategic Growth - TipRanks
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.81%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):